CoChat
Sign Up
Cited by 606Heart Failure Treatment and ManagementAdipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and Adiposity

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure

Kistorp, Caroline, Faber, Jens, Galatius, Søren, Gustafsson, Finn, Frystyk, Jan, Flyvbjerg, Allan, Hildebrandt, Per·2005·Circulation
DOI 10.1161/circulationaha.104.530972
Open this paper in CoChat — free account

Abstract

Background— Recent studies have suggested that higher body mass index (BMI) is associated with improved prognosis in chronic heart failure (CHF). The adipocytokine adiponectin is inversely associated with BMI, and in healthy subjects, low adiponectin is a predictor of mortality. In a prospective study, we therefore evaluated the association between plasma adiponectin levels and mortality among patients with CHF. Methods and Results— In 195 CHF patients (age 69.3±10.2 years, BMI 27.3±5.2 kg/m 2 , left ventricular ejection fraction 30±8.9%, mean±SD), plasma adiponectin and N-terminal pro brain natriuretic peptide (NT-proBNP) were measured at baseline. Adiponectin was positively associated with NT-proBNP (β=0.47, P <0.001), and both biomarkers were negatively associated with BMI (β=−0.43, P <0.001 for adiponectin and β=−0.38, P <0.001 for NT-proBNP, respectively) During a median follow-up of 2.6 years, 46 (23.5%) of the patients died. After adjustment for clinical variables associated with CHF severity (age, systolic blood pressure, left ventricular ejection fraction <25%, duration of CHF, and creatinine clearance) and for NT-proBNP, the hazard ratio of mortality for values in the 2 upper tertiles relative to the lowest tertile of adiponectin was 3.23 ( P =0.032). BMI predicted mortality independently of clinical parameters of CHF severity (hazard ratio=0.63, P =0.012), but this association became insignificant after additional adjustment for NT-proBNP (hazard ratio=0.74, P =0.13). Conclusions— A high adiponectin level was a predictor of mortality, independent of risk markers of CHF severity, presumably because of its role as a marker for wasting. BMI was also associated with mortality, but a part of this relation may be mediated by adiponectin and NT-proBNP levels.

Overview

Integrity signals

Registry

Crossref · 10.1161/circulationaha.104.530972

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. 10.1161/atvb.20.6.1595 · DOI
  2. 10.1210/jcem.86.8.7741 · DOI · Paper page

Cited by

Sorted by citations

See all 606

Related

See all

Metadata

Authors
Kistorp, C., Faber, J., Galatius, S., Gustafsson, F., Frystyk, J., Flyvbjerg, A., & Hildebrandt, P.
Affiliations
Frederiksberg Hospital (DK)
ORCID
Venue
Circulation
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2005-09-20
Volume
112
Issue
12
Pages
1756-1762
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
DOI
10.1161/circulationaha.104.530972
OpenAlex
W2072526806
Cited by
605
References
39
Citations by year
2026: 4 · 2025: 8 · 2024: 8 · 2023: 22 · 2022: 21 · 2021: 13 · 2020: 20 · 2019: 17 · 2018: 12 · 2017: 25 · 2016: 32 · 2015: 18 · 2014: 23 · 2013: 48 · 2012: 48
FWCI
29.96
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
adiponectin, chronic heart failure, body mass index, mortality, NT-proBNP, adipokines, prognostic factors, wasting, obesity paradox, left ventricular ejection fraction
MeSH terms
Adult, Aged, Aged, 80 and over, Chronic Disease, Female, Heart Failure, Humans, Male, Middle Aged, Peptide Fragments, Regression Analysis, Biomarkers, Proportional Hazards Models, Survival Analysis, Natriuretic Peptide, Brain, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review